How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Description:
This study aims to investigate the value of 68Ga-FAPI PET/CT in the efficacy evaluation of advanced unresectable hepatocellular carcinoma patients undergoing systemic antitumor therapy.
Sponsor:
Ruijin Hospital
Contacts:
Jiajia Hujiajiahu@shsmu.edu.cn
13524945287
Government Study Link:
NCT06746194 - Click here to see study onClinicalTrials.gov
68Ga-FAPI
Isotope(s):
Target(s):
- FAP
